New opportunities for continued advantage! 2025 BTC Wu Qingming identifies AI, genomes, and stem cells as key to Taiwan's leadership.

Today (25th), the Executive Yuan Biotechnology Industry Strategy Advisory Committee 2025 (2025BTC) invited Dr. Wu Qingming, currently the Director of the Cardiovascular Center at Stanford University, Professor of the Simon H. Stertzer Department of Medicine and Department of Radiology at Stanford University School of Medicine, and also a member of the Academia Sinica, to attend the first BTC meeting under the "Healthy Taiwan" policy. In the first topic "Advantage Continuation", Dr. Wu Qingming focused on the application and innovation of genetic medicine under the theme of "Al, Genome, Stem Cells - Trends in New Drug Development", shared the latest progress in precision medicine, the potential of artificial intelligence (AI) and stem cell technology in treating genetic diseases, and called on Taiwan to seize the opportunity to become a leader in this field. Source link